Arrowhead Pharmaceuticals 用于神经退行性疾病的siRNA疗法-Developing siRNA for Neurodegenerative Diseases.pdfVIP

  • 1
  • 0
  • 约5.18万字
  • 约 27页
  • 2026-04-10 发布于广东
  • 举报

Arrowhead Pharmaceuticals 用于神经退行性疾病的siRNA疗法-Developing siRNA for Neurodegenerative Diseases.pdf

DevelopingsiRNAforNeurodegenerativeDiseases

ChristineEsau,Ph.D.

RNAattheBenchandBedsideIV

December9,2024

SafeHarborStatement

Thispresentationcontainsforward-lookingstatementswithinthemeaningofthe

safeharborprovisionsofthePrivateSecuritiesLitigationReformAct

文档评论(0)

1亿VIP精品文档

相关文档